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ABSTRACT 
 
 
 
Intraventricular hemorrhaging (IVH) is surprisingly common in premature infants, and 
may cause neurodevelopmental problems.  However, demonstration of this correlation has been 
difficult to obtain at UMass Memorial Medical Center due to a communication disconnect 
between the Neonatal Intensive Care Unit where IVH is usually first diagnosed, and the Follow-
up Clinic where subsequent developmental problems would be identified.  To bridge this 
disconnect, standardized forms were developed to allow physicians to obtain medical follow-up 
data on infants.  The results of a sample analysis of severe IVH show that severe IVH in 
premature infants born under 1000g correlates with neurodevelopmental problems such as 
cerebral palsy, cognitive impairment, and various sensory impairments.  
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BACKGROUND 
 
 
Vermont Oxford Network 
The Vermont Oxford Network (VON) is a worldwide non-profit organization, consisting 
of 850 neonatal intensive care units. Yearly, VON acquires data on approximately 50,000 
infants. VON is a voluntary service of health care professionals working to improve the safety 
and quality of newborn infants' medical care. The network holds an Annual Quality Congress of 
Neonatology for all participating institutions (Vermont Oxford Network, 2011). 
These health care professionals conduct numerous clinical trials, long-term follow-up 
studies, as well as outcome and epidemiologic research. This data is contained in a network 
database and is used to determine information about how newborn infant care influences their 
outcomes. The results of these studies are published by the network in scientific articles, peer 
reviewed medical journals, network publications, and on their website (Vermont Oxford 
Network, 2011). 
The VON database contains information on very low birth weight (VLBW) infants as 
well as others that fit their requirements. VON is able to take information from the database from 
the participating hospitals and provide an analysis and report confidentially on those hospitals. 
This allows hospitals to see which areas can be improved for quality assurance purposes 
(Vermont Oxford Network, 2011). Quality assurance opportunities are also available through 
collaboration with other hospitals through face-to-face contact or through web-based conferences 
(Vermont Oxford Network, 2011). 
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Prematurity 
Infants born before 37 weeks gestation are considered premature. The more preterm an 
infant is born, the greater the risk that the infant will experience complications of prematurity. 
High rates of morbidity and mortality in preterm infants can be attributed to complications 
associated with prematurity. Approximately one third of infant deaths can be associated with 
prematurity. Extremely premature infants have a mortality rate around 50 percent (the highest of 
any gestational age group), as well as having the greatest risk of morbidity in the long-term. 
Prematurity accounts for 25 percent of children with hearing or cognitive impairments, 35 
percent of those with visual impairments, and 45 percent of children with cerebral palsy 
(Eichenwald & Stark, 2008). 
Three standard subdivisions classify underweight infants and three are designated for the 
degree of immaturity (approximate gestational age at birth). Infants born weighing less than 1000 
g are considered to be extremely low birth weight (ELBW). An infant born weighing between 
1000 g and 1500 g is considered to be very low birth weight (VLBW). Infants born weighing 
between 1500 g and 2500 g are considered to be low birth weight (LBW) (WHO, 2011). An 
infant born before 25 weeks gestation is referred to as being extremely preterm (Nicolas et al., 
2000). Infants born between 25 and 32 weeks gestation is referred to as being very preterm. An 
infant born from 32 to less than 37 weeks gestation is referred to as being late preterm (Pamela et 
al., 2004). 
 
Major NICU Advancements 
Advancements in antenatal medicine and neonatal care have improved the rates of 
preterm infant survival. However, this improved rate of survival was not followed by 
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proportional decreases in neurological disabilities (Stephens and Vohr, 2010). Three major 
advancements in neonatology contributing to this increased survival of preterm infants are the 
implementation of antenatal steroids, surfactant therapy, and high frequency oscillation ventilator 
use. 
 
Antenatal Steroids  
 Antenatal steroids are a type of steroid administered intramuscularly to mothers when her 
baby is between 24 and 34 weeks gestation and is at risk for premature birth. Treatment consists 
of two doses of 12 mg of betamethasone or four doses of 6 mg dexamethasone.  Antenatal 
steroids are the most effective 24 hours after administration, and the effects last for seven days. 
Antenatal corticosteroids, administered to pregnant women, cross the placenta to induce cellular 
differentiation. Increased cellular differentiation results in significant reductions in neonatal 
mortality, respiratory distress syndrome (RDS), and intraventricular hemorrhage (IVH) (Norwitz 
et al., 2010).  
 Antenatal steroids aid fetal brain development by supporting the maturation of the 
germinal matrix microvasculature and reducing blood-brain barrier permeability. This increases 
the brain's resistance to stress, decreasing the risk of IVH (Stonestreet et al., 1998). 
 Corticosteroids are essential to fetal lung development. During late gestation, the 
concentration of circulating corticosteroids increases as the lungs mature (Ballard and Ballard, 
1995). Infants born preterm miss this increase in corticosteroids. Fetuses exposed to antenatal 
steroid treatment have increased alveolar volume, closer alignment of alveoli to vessels, and 
thinner alveolar walls compared with non exposed fetuses of a similar gestational age. This leads 
8 
 
to better gas exchange and an enhanced response to postnatal surfactant treatment (Bonanno and 
Wapner, 2009).  
 
Surfactant Therapy 
 Surfactant is a lipoprotein complex, found in the lungs, which reduces alveolar collapse 
by forming a layer between the alveolar surface and the alveolar gas in the lungs, reducing 
surface tension (Berry, 1991). Very premature infants are often not able to produce their own 
surfactant because their type II alveolar epithelial cells, where surfactant is produced, have not 
matured. Without surfactant, the alveoli may not inflate or collapse on expiration, which can lead 
to respiratory distress syndrome (RDS) (Berry, 1991). Exogenous surfactant is the primary life-
saving therapy for RDS in preterm infants (Ramanathan, 2009). There are two strategies for 
surfactant administration; prophylactic (or preventative) treatment, and rescue or therapeutic 
treatment (Ramanathan, 2009). 
 
High Frequency Oscillation Ventilator  
 High frequency oscillatory ventilation (HFOV) is a mechanical ventilator that uses 
constant distending pressure, with pressure variations oscillating around the mean airway 
pressure. This ventilation strategy produces small tidal volumes, in contrast to conventional 
ventilators, which induces large pressure changes and gas volumes, and is associated with 
ventilator induced injury. HFOV uses alternative mechanisms of gas exchange, such as 
molecular diffusion.  Consequently, HFOV has become the most accepted mode of ventilation 
support for RDS in VLBW infants, and has been shown to improve survival without an increase 
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in the incident of chronic lung disease (Moriette et al., 2001; Johnson et al., 2002; Kessel et al., 
2010). 
 
Short Term Complications of Prematurity 
It is important to quickly stabilize infants in the delivery room to reduce their risk of 
developing short term complications (Lemons et al., 2001). Short term complications of 
prematurity are defined as those occurring during the neonatal period (Eichenwald & Stark, 
2008). Premature infants are increasingly susceptible to developing short term complications 
with decreasing birth weight and gestational age, and are the result of anatomical or functional 
immaturity (Faranoff et al., 2007).  
Retinopathy of prematurity (ROP) is a condition occurring around 34 weeks 
postmenstrual age, and occurs when the retina of premature infants is incompletely vascularized. 
ROP generally spontaneously resolves, but requires treatment when ROP is severe and does not 
resolve spontaneously (Palmer et al., 1991). Infants with ROP are more likely to have vision 
impairment or poor ocular outcome (Trese and Droste, 1998; Moshfeghi et al., 2004; Prenner et 
al., 2004; Lakhanpal et al., 2005; Repka et al., 2006). 
Many VLBW infants need resuscitation at birth, most requiring endotracheal intubation 
and others only need resuscitation medications. Prophylactic administration of surfactant reduces 
the risk of respiratory complications, such as respiratory distress syndrome (RDS), pulmonary 
interstitial emphysema, and pneumothorax (Lemons et al., 2001). Other complications include 
bronchopulmonary dysplasia (BPD), and apnea of prematurity (Henderson-Smart, 1981; Frank 
and Sosenko, 1987). Respiratory distress syndrome (RDS) results from insufficient surfactant 
production prior to birth (Frank and Sosenko, 1987) and occurs about 93 percent of the time 
10 
 
(Stoll et al., 2010). A symptomatic patent ductus anteriosus (PDA) occurs in about 46 percent of 
VLBW infants (Stoll et al., 2010). BPD is a chronic lung disease defined as dependence upon 
oxygen at 36 weeks postmenstrual age, occurring late in the neonatal period (Shennan et al., 
1988; Marshal et al., 1999) in approximately 42 percent of infants (Stoll et al., 2010). Apnea of 
prematurity occurs in about 25 percent of premature infants (Henderson-Smart, 1981). 
Necrotizing enterocolitis (NEC), a gastrointestinal complication, increases the risk of 
neurodevelopmental disabilities (Rees et al., 2007; Schulzke et al., 2007) and growth delay later 
in life (Hintz et al., 2005). 
Late-onset sepsis, or a positive blood culture occurring after three days of age, occurs in 
about 21 percent of VLBW infants (Stoll et al., 2002). Neonatal sepsis is also associated with an 
increase in growth impairment and poor neurodevelopmental outcomes later in life (Stoll et al., 
2004). 
Short term cardiovascular complications include a patent ductus anteriosus (PDA) and 
systemic hypotension (Faranroff et al., 2007; Seri and Noori, 2005). PDA causes increased blood 
flow through pulmonary circulation and decreased blood flow through systemic circulation by 
shunting the blood from left to the right side of the heart (Rudolph, 1970). If a significant amount 
of shunting occurs, symptoms such as respiratory distress, apnea, or heart failure may present 
(Thibeault et al., 1975; Cotton et al., 1978; Jacob et al., 1980; Mahony et al., 1982; Cassady et 
al., 1989; Schmidt et al., 2001). Systemic hypotension, occurring immediately after birth, can 
lead to the development of IVH (Seri and Noori, 2005; Osborn et al., 2007; Miletin and 
Dampsey, 2008). 
Overall, the more short term complications seen in an infant, the greater the chances that 
the child will experience long term complications of prematurity (Eichenwald and Stark, 2008). 
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Preterm Brain Complications  
 A child born very preterm uses different regions of the brain to process information than 
those regions a term infant uses. When an infant is born prematurely, the brain compensates for 
being underdeveloped to function properly in its new environment. These changes can have 
detrimental effects in long term (Jobe, 2010). The preterm infant born at 24 weeks gestational 
age has a brain weight around 100g with a smooth surface with no external architecture (gyri). 
While at full term, an infant’s brain weighs about 350g and has a convoluted surface and great 
complexity (Ment et al., 2009). The brain of an ELBW neonate grows, but the surface structure 
is less complex than the full term brain (Ajayi-Obe et al., 2000). A preterm brain has a lower 
volume of deep nuclear grey matter, which can be further damaged by white matter injury (Inder 
et al., 2005).  
 New born brain injury occurs as often as 1 in 4000 live births. Greater than 95% of 
infants who survive a brain injury survive until adulthood, but many suffer motor and cognitive 
disabilities (Nelson and Lynch, 2004). Therefore, it is important to examine the brain 
complications of preterm infants whose susceptibility for brain injury is higher than that of term 
infants. Neonatal brain injury is difficult to detect in VLBW infants due to the absence of some 
common signs of brain injury, including lethargy, hyperexcitability, and stupor (Mercuri et al., 
2003).  
 Preterm infants are predisposed to brain injury due to factors including hypoxia, 
ischemia, hyperoxia, and maternal-fetal infection. Perinatal impacts to the brain can result in 
inflammation, excitotoxicity, and oxidative stress. Genetic factors cause some infants to be more 
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susceptible to these complications. These factors contribute to encephalopathy of prematurity, 
which is white and grey matter damage of the premature brain (Kaindl et al., 2009).  
 The most common brain injury in preterm infants is periventricular white-matter injury. 
Periventricular white matter injury is the primary cause of chronic neurological morbidity (Deng 
et al., 2008). Periventricular leukomalacia (PVL), the most common type of white matter injury, 
is marked by microglial activation and depletion of premyelinationg oligodendrocytes (Kaindl et 
al., 2009). Neuropathological studies have found that diffuse white matter damage is 
characterized by a lack of white matter, thinning of the corpus callosum, and delayed 
myelination. This is caused by death of late oligodendrocyte progenitor cells
 
(Back et al. 2001). 
 White-matter damage is accompanied by neuronal loss and impaired neuronal guidance. 
Some preterm infant complications result from reduced connectivity between areas of the brain 
needed for integrating information (Kadhim et al., 2003; Kesler et al., 2006; Leviton and 
Gressens, 2007; Okoshi et al., 2007).  
 The neonatal brain is vulnerable to oxidative damage because of its high concentrations 
of unsaturated fatty acids, high rates of oxygen consumption, low concentrations of antioxidants, 
and availability of redox-active iron (Halliwell, 1992). In the immature brain, oligodendrocyte 
progenitor cells are susceptible to the depletion of antioxidants and exposure to free radicals, 
while mature oligodendrocytes are extremely resistant to this stress (Baud et al., 2004). This 
vulnerability gives reason to white matter injury occurring more often in preterm infants. 
Oxidative stress can lead to ischemic damage to the neonatal brain. Ischemia is a decrease in the 
blood supply caused by constriction or obstruction of blood vessels. This leads to tissue damage 
because of a lack of oxygen and nutrients (Kanold et al., 2003).  
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 Excitotoxicity is also a factor in ischemic damage to the preterm brain. Excitotoxicity is 
the excessive activation of glutamanergic neurotransmitters leading to cell death (Olney, 2003). 
This cell death in the neonate brain may be triggered by the impairment of the uptake of 
glutamate by glia causing overactive receptors (McDonald and Johnston 1990). The expressions 
of these glutamate receptors dictate the reaction of a newborn to brain injury. Blocking these 
receptors protects against hypoxic-ischemic injury to the white matter (Deng et al., 2004).  
 Maternal infection is another factor associated with white matter disease in the premature 
brain. Chorioamnionitis, inflammation of the amnion and chorion due to bacterial infection, is a 
risk factor for preterm infants (Wu et al., 2003). The problem with this association is that it is 
difficult to define chorioamnionitis, as it is rare to document it by histological examination of the 
placenta. This condition can be as vague as maternal fever (Khong et al., 2000).  
 Neonatal strokes often originate arterialy, and are caused by ischemic damage, but about 
30 percent are caused by sinovenous thrombosis (deVeber et al., 2001; Wu et al., 2004). Risk 
factors of neonates with stroke due to cerebral venous thrombosis include coagulation 
abnormalities, certain genetic mutations and polymorphisms (Mercuri et al., 2001). The risk of 
reoccurring neonatal stroke is low at 5 percent, and is associated with complications of systemic 
disorders (Kurnik et al., 2003).  
 
Intraventricular Hemorrhage 
A decline in the incidence of intraventricular hemorrhage (IVH) has been seen since the 
1980s where IVH occurred 50 to 80 percent of the time.  It now occurs at the rate of 10 to 15 
percent. The increased survival of extremely premature infants ensures that IVH remains a 
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significant problem in infants. Intraventricular hemorrhage, in premature infants, is a leading 
cause of brain injury (Volpe, 2001).  
Intraventricular hemorrhage, as its name implies, is bleeding in or around the ventricles 
of the brain, which function to store cerebral spinal fluid. There are four grades of IVH. In Grade 
1 IVH bleeding occurs on the edge of the ventricles but does not extend into the ventricles. In 
IVH Grade 2 bleeding has progressed into the ventricles. In Grade 3 IVH the ventricles have 
become enlarged due to the bleed. Grade 4 IVH, the most severe, is present when bleeding is so 
severe that blood is forced into the tissue surrounding ventricles. IVH Grades 1 and 2 typically 
do not result in further complications. IVH Grades 3 and 4 (severe IVH) are less common, and 
can result in permanent damage to the brain (Lucile Packard Children's Hospital at Standford, 
2011). Infants with severe IVH face a mortality rate near 20 percent, with more than 50 percent 
developing progressive ventricular dilation (Volpe, 2001).  
IVH most commonly occurs in infants less than 1500 g or less than 32 weeks gestation. 
Ninety percent of IVH occurs within the first three days of life (Volpe, 2001). IVH is rarely 
isolated, and is often accompanied by periventricular leukomalacia (PVL) (Armstrong et al., 
1987) a contributing factor of IVH (Guzetta et al., 1986). Other contributing factors include 
periventricular hemorrhagic infarction, and parenchymal injury (Guzetta et al., 1986).  
IVH typically occurs in the frail germinal matrix (Fanaroff et al., 2007; Stoll et al., 2010). 
The germinal matrix is the richly vascularized and highly cellular layer of the subependymal 
subventricular zone, region of the brain that gives rise to glia and neurons during infant 
development (Sidman et al., 1982). Infants are predisposed to hemorrhage if the structural 
support of the germinal matrix is insufficient (Grunnet, 1989). Astrocytic support of blood 
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vessels in the germinal matrix at 27 weeks gestation is minimal, and at 31 weeks is much more 
prominent (Gould and Howard, 1987). 
The best method for preventing IVH would be to prevent a premature birth, but antenatal 
corticosteroid administration significantly reduces the risk of the IVH when premature birth 
cannot be prevented (Crowley, 2000). Some common preventative measures include maintaining 
hemodynamic stability, efforts to prevent conditions that disrupt cerebral autoregulation, and 
appropriate and timely resuscitation (Jim et al., 2005). Clamping the umbilical cord after thirty 
seconds following birth is also associated with a decrease in the incidence of IVH (Rabe et al., 
2004; Mercer et al., 2006). 
Risk factors for IVH include prolonged resuscitation, respiratory distress syndrome (Palta 
et al., 2008), pneumothorax, seizures, and necrotizing enterocolitis (Goddard-Finegold et al., 
1997; Jen et al., 2006). Additionally, infants younger than 33 weeks gestation, whose mother had 
chorioamnionitis show an increased risk of developing severe IVH (Soriasham et al., 2009).  
Infants born prematurely are less able to regulate cerebral blood flow which results in a 
pressure passive circulation in which a rise in systemic blood pressure results in an increase in 
cerebral blood flow, damaging the delicate germinal matrix (Papile et al., 1978; Perlman et al., 
1981; Wallin et al., 1990). As infants mature, the range of blood pressures over which they are 
able to autoregulate increases (Papile et al., 1985). Autoregulation can be impaired due to 
asphyxia (Pryds et al., 1990), hypoxia, hypocarbia, hyperoxia, and hypercarbia (Jim et al., 2005).  
Activities such as movement, feeding, and crying, medical interventions such as 
suctioning and endotracheal intubation as well as pathologic states including seizures (Goddard-
Finegold et al., 1997; Volpe, 2001) and pneumothorax can all induce hypertension (Goddard-
Finegold et al., 1997) resulting in an increased chance of developing IVH.  Premature infants 
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who have spontaneous motor activity or undergo intensive care procedures resulting in an 
increase in their systemic blood pressure are more likely to develop IVH.  
It is uncommon for severe IVH to occur in term infants, occurring in them most 
frequently with the rupture of a vascular malformation (Heafner et al., 1985), alloimmune 
thrombocytopenia (Mao et al., 1999), sinvenous thrombosis (Wu et al., 2003), trauma, such as 
abdominal compression (Wehberg et al., 1992), and a diagnosis of hemophilia (Tarantino et al., 
2007).  
IVH presentation can be catastrophic, saltatory, or (in 25-50 percent of cases) clinically 
silent. Catastrophic presentation of IVH is the least common, and is characterized by 
inappropriate antidiuretic hormone (ADH) secretion, bradycardia, hypotension, falling 
hematocrit levels, and a bulging anterior fontanel.  Other signs of catastrophic IVH include 
cranial nerve abnormalities, such as the pupils being fixed to light, generalized tonic seizures, 
decerebrate posturing, flaccid weakness, irregular respirations such as, apnea or hypoventilation, 
and coma or stupor. In a saltatory presentation of IVH, respiratory function is sometimes affected 
as well as the presence of hypotonia, an altered level of consciousness, and a decrease in subtle, 
spontaneous, or elicited eye movements. Saltatory presentation of IVH typically occurs within 
hours to several days (Tarby and Volpe, 1982).  
Diagnosis of IVH is most commonly done via cranial ultrasound. Cranial ultrasounds of 
IVH Grades 1, 2, 3 are shown in Figures 1, 2, 3 and 4, respectively below.  Cranial ultrasound 
screening for IVH is routinely performed on premature infants because nearly half of all 
incidences of IVH are clinically silent (Ment et al., 2002).  Another diagnostic measure used to 
detect IVH is a lumbar puncture. With a lumbar puncture, the cerebral spinal fluid (CSF) of an 
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individual with IVH would contain high protein concentrations and red blood cells (Volpe, 
2001). 
 
 
Figure 1: Cranial ultrasound of Grade 1 IVH (coronal view). The ultrasound 
shows bleeding in the germinal matrix but does not extend into the ventricles. (© 
Auckland.  
http://www.adhb.govt.nz/newborn/TeachingResources/Radiology/HUSS/Images/IVH/Grade1/Grade
%201%20coronal.jpg) 
 
 
 
Figure 2: Cranial ultrasound of Grade 2 IVH (coronal view). The ultrasound 
shows bleeding extending into the ventricles, but does not result in extension of 
the ventricles. (© Auckland 
http://www.adhb.govt.nz/newborn/TeachingResources/Radiology/HUSS/Images/IVH/Grade2/Grade
2Coronal2.jpg) 
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Figure 3: Cranial ultrasound of Grade 3 IVH (coronal view). The ultrasound 
shows a bilateral bleed causing extension of the ventricles. (© Auckland 
http://www.adhb.govt.nz/newborn/TeachingResources/Radiology/HUSS/Images/IVH/Grade3/Day%
202b.jpg) 
 
 
 
Figure 4: Cranial ultrasound of Grade 4 IVH (coronal view). The ultrasound 
shows a bilateral bleed extending past the ventricles into the brain tissue. (© 
Auckland 
http://www.adhb.govt.nz/newborn/TeachingResources/Radiology/HUSS/Images/IVH/Grade3/Day%
204a.jpg) 
 
Supportive treatment to limit the damage of IVH includes aiming to minimize further 
complications, as well as preserving cerebral perfusion. Treatment can include providing 
nutritional, fluid and metabolic support, as well as maintaining systemic blood pressure to 
prevent hypertension or hypotension, and the use of supportive oxygenation and ventilation 
techniques (Volpe, 2001). 
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The severity of the long term outcomes increases with the severity of IVH as well as 
decreasing gestational age and birth weights (Sherlock et al., 2005). Some of the long term 
complications of IVH include cognitive dysfunction, cerebral palsy, major neurosensory 
disabilities (Sherlock et al., 2005), and intellectual disability (formerly reported as mental 
retardation) (Luu et al., 2009). Other complications include posthemorrhagic hydrocephalus, and 
major cognitive impairments, as well as other developmental disabilities (Pinto-Martin et al., 
1999; Murphy et al., 2002). Many children with these complications require special education 
services in school (Vhor et al., 2003). Adverse neurodevelopmental outcomes are greatest among 
those ELBW infants having severe IVH (Adams-Chapman et al., 2008; Brouwer et al., 2008).  
 
Long Term Complications of Prematurity 
Premature children generally have a lower body mass index, are shorter, lighter, and have 
a smaller head circumference than those born full-term due to reduced growth (Bracewell et al., 
2008). Children born preterm have increased prevalence of chronic medical conditions such as 
gastroesophageal reflux (Omari et al., 1998), bronchopulmonary dysplasia (Jobe & Bancalari, 
2001), as well as having an increased risk of hearing (Thompson et al., 2001) and vision 
impairments (Knight-Nanan & O'Keefe, 1996; Hebbandi et al., 1997; Repka et al., 1998; Quin et 
al., 1998; Holmstrom et al., 1999) and sudden infant death syndrome (Verma & Sridhar, 2003).  
Premature infants are more likely to be rehospitalized for recurrent illnesses including 
feeding problems (Korvenranta et al., 2009),  surgical issues (Harper et al., 1975; Peevy et al., 
1986; Powell et al., 1986; Rajput et al., 1992; McCourt & Griffin, 2000), infections, notably 
respiratory syncytial virus infection (Nachman et al., 1997; McCormick & Tubman, 2002), and 
respiratory problems including asthma compared to infants born full-term (Koivisto, 2005; 
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Underwood et al., 2007). Premature children also have an increased risk of having impaired lung 
function, which may result in an increase in respiratory symptoms, and a reduced exercise and 
lung capacity (Smith et al., 2008). 
In ELBW children, neurodevelopmental complications result in more functional 
limitations such as developmental, growth and motor delay, as well as decreased social skills, 
limited physical ability, and sensorineural deficits. Children born ELBW are also more likely to 
require equipment or help for activities of daily life such as washing, dressing and feeding, as 
well as increased medication use. In addition, ELBW children are at increased risk of requiring 
additional services such as educational programs individualized to their needs, other special 
school arrangements, and acute care visits to specialized health care professionals than children 
born at a normal birth weight (Stein et al., 2006). 
As adults, those born prematurely seem to be more likely to have higher blood pressure 
and an increased resistance to insulin compared to adults born full-term (Hovi et al., 2007; 
Rotteveel et al., 2008). During their late teens, ELBW adults score higher on measures of 
inattention, anxiety, depression, withdrawn behavior, and social problems. In addition, VLBW 
adults in the same age group report lower rates of alcohol and drug use, sexual activity, and 
pregnancy than adults born at normal birth weight (Hack et al. 2004). An association can be 
made between decreased reproduction in adulthood and prematurity compared to the 
reproductive rates of full-term adults. Additionally, women who were preterm also have a higher 
risk of having a preterm child. However, men born prematurely have no increased risk of their 
children being born prematurely (Swamy et al., 2008). 
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Neurodevelopmental Outcomes of Premature Infants 
 Common neurological impairments associated with prematurity include mental 
retardation (cognitive impairment), cerebral palsy (CP), blindness, and hearing impairments.  
These are the highest in ELBW infants (Hack and Farnaroff, 2000). Research centers and 
hospitals have reported a range of occurrences of neurological impairment. The variability of this 
data can be contributed to rates of neonatal morbidities and differences in treatment management 
style (Vohr et al., 2004).  
 The most common neurological impairment is cognitive impairment, which is defined as 
a score more than two standard deviations below the mean on standardized cognitive tests 
(Bayley, 1993). Rates of cognitive impairment are inversely proportional to gestational age and 
birth weight. While testing of cognition is done during infancy, it is not always predictive of 
cognitive function later in life (Jobe, 2010).  
  ELBW and VLBW school age children have lower Intelligence Quotient (IQ) scores and 
higher rates of cognitive impairment compared with their normal peers (Marlow et al., 2005). 
Compared with their normal peers, VLBW and ELBW children have impairments of executive 
functioning, visual-motor skills, and memory. Infants born LBW are also more likely to develop 
learning disabilities such as attention deficit disorder or attention deficit hyperactivity disorder 
(Hack et al., 2002).  
 Other neurological impairments of prematurity affect motor functions. The main concern 
here is cerebral palsy (CP). Cerebral Palsy is defined as “a disorder of movement and posture 
that involves abnormalities in tone, reflexes, coordination and movement, delay in motor 
milestone achievement, and aberration in primitive reflexes (Vohr et al., 2005).”  The most 
common form of CP is spastic diplegi: spastic quadriplegia, and hemiplegia (Bracewell and 
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Marlow, 2002; Vohr et al., 2005; Stephens and Vohr, 2010). Some LBW infants develop soft 
neurological signs of motor impairment. Soft signs include deviations in speech, balance, 
coordination, gait, tone, and fine motor or visual motor tasks that do not signify localized brain 
dysfunction (Breslau et al., 2000). Standard evaluations of motor function include muscle tone, 
strength, reflexes, joint angles, and posture. 
 Neurosensory disabilities are not as common as cognitive and motor impairments, but are 
prevalent in ELBW infants. Visual impairments include unilateral or bilateral blindness, myopia, 
and strabismus. Hearing impairments requiring amplification occur in 1% to 9% of ELBW 
infants (Vohr et al., 2004). Mild hearing impairments are more common (Hack et al., 2005).  
 Prematurity, especially VLBW infants, has been associated with many behavioral and 
psychological diagnoses and disabilities. Evaluation of behavior is often obtained by parents and 
teachers and measures behavior, attention, adaptive skills, and depression. There is concern that 
low birth weight and gestational age presents a risk for autism spectrum disorders, but the true 
risk is unknown (Schendel and Bhasin, 2008).  
 
Diagnostic Developmental Tests 
The Bayley Scales of Infant Development - Second Edition (BSID-II) is a developmental 
test of both cognitive and motor skills for infants one month to 42 months (Bayley Scale, 2011). 
BSID-II has three characterized scales evaluating the mental (mental scale), motor (motor scale), 
and behavioral development (behavioral scale) of a child (BSID-II, 2011). The mental scale 
gives a normalized Mental Developmental Index (MDI) and Psychomotor Development Index 
(PDI) standard score (BSID-II, 2011). The motor scale tests large muscle coordination, degree of 
body control, fine manipulatory skills involving he fingers and hands as well as stereognosis, 
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dynamic movement, dynamic praxis, and postural imitation (BSID-II, 2011). The behavioral 
scale is an assessment of the child's ability to perform the mental and motor tests looking at 
motor quality, orientation/engagement, attention/arousal, as well as emotional regulation and is 
used as a supplementary scale to the mental and motor scales (BSID-II, 2011).  
The BSID-II was normalized to a sample of 1,700 children randomly selected infants 
between the ages of one month to 42 months (BSID-II, 2011). The manual for the BSID-II 
provides information about specific groups as reference, including children who have the HIV 
antibody, Down's syndrome, are developmentally delayed, are autistic, have frequent ottis media, 
were asphyxiated at birth, who were prenatally exposed to drugs, or were born prematurely 
(BSID-II, 2011). 
The Bayley Scales of Infant and Toddler Development --Third Edition (Bayley-III) also 
tests children from one month to 42 months of age (Bayley-III, 2011). The Bayley-III is similar 
to the BSID-II in the fact that they are both testing the same basic aspects of development; 
however the Bayley-III is a bit more comprehensive. The Bayley-III has five scales 
corresponding to the five developmental domains in which the children are evaluated: social-
emotional, adaptive behavior, cognitive, motor, and language development (Bayley-III, 2011). 
The Bayley-III focuses on the developmental skills the child possesses, but also has scores 
children with a scaled and composite score in the fields of cognition, motor (fine and gross 
motor), and language (both receptive and expressive language) (Bayley, 2006).  
The social-emotional domain of the Bayley-III is meant to monitor emotional and social 
functioning, the progress of early intervention, as well as determining if the child has mastered 
the early aspects of their social-emotional growth, age related milestones and detecting 
developmental social-emotional problems or deficits (Bayley-III, 2011).  
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The adaptive behavior domain of the Bayley-III includes self-care, self-direction, health 
and safety, home living, leisure, functional pre-academics, social, motor, communication, and 
community use (Bayley-III, 2011). 
The cognitive domain of the Bayley-III includes exploration and manipulation, 
habituation, memory, concept formation, object relatedness, sensorimotor development, visual 
preference, visual acuity, as well as object permanence and other cognitive processing abilities, 
as well as age-appropriate cognitive skills (Bayley-III, 2011). The motor domain of the Bayley-
III includes gross motor and fine motor skills on which the children are evaluated (Bayley-III, 
2011). The language domain of the Bayley-III is comprised of two communication groups: 
expressive communication and receptive communication (Bayley-III, 2011).  
The manual for the Bayley-III includes reference material on children who are premature, 
small for gestational age, at-risk, have Down's syndrome, pervasive developmental disorder, 
cerebral palsy, language impairment, and FAS/polysubstance use (Bayley-III, 2011). The scores 
generated by the Bayley-III include information on percentiles, age equivalents, T score, and cut 
scores (Bayley-III, 2011). 
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PROJECT PURPOSE 
 
The purpose of this project was to bridge the information disconnection between the 
neonatal intensive care unit (NICU) at the UMass Memorial Medical Center (where IVH is first 
likely to be diagnosed) and their Developmental and Behavioral Pediatric Follow-Up clinic 
(where subsequent developmental outcomes are first identified).  Physicians from the NICU at 
UMass Memorial Medical Center require information for parents facing the decision as to 
whether to continue life sustaining care premature infant when he/she has a particular neonatal 
complication. Standardized health and developmental follow-up forms are needed for physicians 
in the NICU to attain follow-up data on children who suffered from similar conditions in the 
NICU.  With this information parents can understand what complications their premature infant 
my face later in life and will be better able to make an informed decision on whether to continue 
to provide life-sustaining care to their infants with severe IVH who may be neurologically 
devastated.  In this project, an analysis of infants with severe IVH born under 1000g was 
performed to demonstrate potential correlations with neurodevelopmental follow-up statistics. 
Physicians can use this information to show parents the neurodevelopmental outcomes of severe 
IVH infants at UMass and the chances of their Infant with IVH developing neurological 
impairments.  
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METHODS 
 
Pediatric Follow-Up Form Development 
 
 Standardized Follow-up Health Status and Developmental Status forms were created for 
use by the UMass Pediatric Developmental and Behavioral Follow-up Clinic and neonatal 
intensive care unit (NICU) to track the development of children after discharge from the NICU. 
These forms were based on the Vermont Oxford Network (VON) Forms (Appendicies 1a & b) 
and altered to fit the needs of UMass Memorial Medical Center (UMMC). VON evaluates 
infants between 18 and 24 months but the follow-up clinic sees children of all ages, thus there is 
a wider range of information to collect.   
 Dr. Robin Adair of the UMass follow-up clinic and Dr. Alan Picarillo of the UMass 
NICU were interviewed to identify what information needed to be captured during follow-up 
visits. These discussions provided insight on which data the follow-up clinic captures for 
children at different ages, and what information is necessary for neurodevelopmental diagnosis. 
Developmental and Behavioral Pediatric Follow-up appointments were observed to better 
understand the process of diagnosis.   
 The UMMC Follow-up Health Status and Developmental Status forms were designed for 
a relatively new database system at the follow-up clinic, AllScripts.  The forms were designed 
with Microsoft Word, and numerically coded for electronic entry.  A total of seven forms were 
developed and are listed in Table 1.   
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Table 1: UMass follow-up Clinic Forms  
 
   Age Range 
Form          (Months . Days) 
 
Developmental Status  0.0 – 15.29 
Developmental Status  16.0 – 26.0 
Developmental Status  26.1 – 42.0 
Developmental Status  >42.1 
Health Status   0.0 – 15.29 
Health Status   16.0 – 26.0 
Health Status   >26.1 
 
 
Severe IVH Database Setup 
 
 Infants born under 1000g with severe IVH (grades 3 and 4) were studied to determine 
trends in neurodevelopment. An Excel database was set up including all infants with severe IVH, 
born under 1000 grams, at the UMMC NICU from 2003 to 2009 (n = 17). Because past 
information was not recorded on the newly developed follow-up forms, data was extracted from 
paper files and was recorded in the excel database.  Independent variables included all perinatal 
conditions. Dependent variables were all neurodevelopmental follow-up conditions. 
Neurodevelopment conditions were determined by the physicians at the UMMC Pediatric 
Follow-up Clinic. A list of the independent and dependent variables used in data analysis are 
provided in Table 2. 
Table 2: Severe IVH Independent and Dependent Variables  
 
Independent Variables 
(Perinatal Conditions) 
Dependent variables  
(Neurodevelopmental) 
 
Grade of IVH 
 
Early Intervention 
Mode of Delivery Cerebral Palsy (CP) 
Antenatal Steroids Rehospitalization 
 Bayley II MDI scores 
 Bayley III scores 
 Prescription Glasses 
 Hearing Impairment 
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 A comprehensive list of variables collected can be found in Appendix 2. 
 
 
Data Analysis 
 
 The data collected in the severe IVH database (n=17) was compared to infants born at 
UMMC between 2003 and 2009 that were under 1000g but did not have severe IVH (n = 179) 
and infants born between 2003 and 2007, under 1000g in the VON data base (n = 85175).  A two 
tailed Fisher’s Exact Test, (Quick Calcs, 2005), was used to compare the occurrence of the 
neurodevelopmental outcomes in the different populations.  The two tailed Fisher’s Exact Tests 
are listed in Table 3. 
 
Table 3:  Two Tailed Fisher’s Exact Tests 
 
1. Cerebral Palsy: Severe IVH Infants vs. No Severe IVH Infants (UMass) 
2. Severe Cognitive Impairment vs. No Severe Cognitive Impairment: Severe IVH Infants 
vs. No Severe IVH Infants (UMass) 
3. Moderate Cognitive Impairment vs. No Cognitive Impairment: Severe IVH Infants vs. No 
Severe IVH Infants (UMass) 
4. Eyeglasses: Severe IVH Infants vs. No Severe IVH Infants (UMass) 
5. Hearing Impairment: Severe IVH Infants vs. No Severe IVH Infants (UMass) 
6. Rehospitalization: Severe IVH Infants vs. No Severe IVH Infants (UMass) 
7. Grade of Severe IVH (3 or 4): Use of Antenatal Steroids 
8. Grade of Severe IVH (3 or 4): Mode of Delivers (Vaginal Delivery or Cesarean Section) 
 
 The occurrence of severe IVH and cerebral palsy in infants born under 1000g at UMMC 
and in VON was compared.  The occurrence of severe IVH was compared to see how UMMC 
compares to the average NICU that submits data to VON.  The occurrence of cerebral palsy was 
used as a positive control in which to compare UMMC and VON.  A Two Tailed Fisher’s Exact 
Test could not be used for these comparisons because of the large number of infants, so a Chi 
Squared Analysis with a Yates Correction was used for these comparisons.  
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 The cognition levels of these children were determined by examining their Bayley II and 
III test scores completed between ages 14 and 26 months.  Some children were given either the 
Bayley II or III.  If both test were administered the Bayley III was used for analysis.  The Bayley 
II has one index score for cognition termed the Mental Development Index (MDI) score.  Scores 
of 85 or above are considered normal, scores 70 to 84 are considered moderately impaired and 
scores below 70 are considered severely impaired.  The Bayley III test produces multiple scores 
so as advised by Dr. Robin Adair and Dr. Alan Picarillo, the Cognitive Index scores and 
Language Index scores were averaged to determine an equivalent MDI score. The average of 
these scores was used to determine the degree of cognitive impairment. Again, scores of 85 or 
above are considered normal, 70 to 84 are considered moderately impaired and scores below 70 
are considered severely impaired.  All other neurodevelopmental outcomes were found directly 
in the patients’ paper charts. 
 The Fisher’s Exact Test was used to compare the occurrence of neurodevelopmental 
outcomes in different infant populations, calculate the probability that a difference in two 
categories is a significant difference or a coincidence (not significant).  The Fisher’s Exact Test 
calculated P values for each comparison.  The P value is the probability that a difference will be 
observed that is as large as or larger than observed if the null hypothesis were true.  The Null 
hypothesis for each of these comparisons was that there is no difference between the groups.  A 
P value of 0.05 or less is considered to suggest a significant difference between two groups.  
Meaning there is only a 5% chance that the difference is insignificant.   
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RESULTS 
 
 
This project helped bridge the information disconnection between the neonatal intensive 
care unit (NICU) at the UMass Memorial Medical Center (UMMC) and their Developmental and 
Behavioral Pediatric Follow-UP Clinic.  Physicians from the NICU will now be able to more 
efficiently acquire information from the Follow-Up Clinic from the developed Health and 
Developmental Status Forms, which will be used in the AllScripts database.  The new Health and 
Developmental Status Forms can be found in Appendices 3a-g.  This information will enable 
parents to understand what complications their premature infant may face later in life. 
 An analysis if infants with severe intraventricular hemorrhage (IVH) under 1000g was 
conducted to demonstrate the advantages of the Health and Developmental Status Forms in the 
attainment of neurodevelopmental follow-up statistics.  The results show that severe IVH in 
premature infants born under 1000g correlates with certain neurodevelopmental complications.  
All but one of the severe IVH infants received Early Intervention to assist in their 
neurodevelopment. 
 A positive control was performed to ensure that UMass and the Vermont Oxford 
Network (VON) had accurate follow up data. As a positive control, the occurrence of cerebral 
palsy (CP) in ELBW infants, from 2003 to 2007, was compared between UMMC and VON. The 
occurrence of CP was used because it is a possible neurodevelopmental outcome of any ELBW 
infant.  A Two-tailed Fisher’s Exact Test indicated no difference in the occurrences of CP in 
either population. Because there is no significant difference between the two populations, the 
positive control indicates that these two populations are comparable, and therefore the results of 
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the statistical analysis between the groups are reliable.  A Graph of the Occurrence of CP in 
ELBW infants at both UMass and Von is displayed in Figure 5. 
  
 
Figure 5: Occurrence of Cerebral Palsy in ELBW Infants: UMass vs. VON. 
The occurrence of cerebral palsy at UMass compared to the VON Network.  This functions as a 
positive control showing no statistical difference in the overall occurrence of cerebral palsy at 
UMass (n=187) compared to the VON Network (n=4007) with a P value of 0.0692.  
 
 To determine how well UMMC is stabilizing ELBW infants and preventing severe IVH, 
The occurrence of severe IVH in ELBW infants, between 2003 and 2007, was compared 
between UMMC and VON using a Chi Squared analysis with Yates correction.  The analysis 
showed that the occurrence of severe IVH in ELBW infants at UMass was statistically 
significantly lower than infants reported to the national Vermont Oxford Network database.  A 
Graph of the occurrence of severe IVH at UMass and VON is displayed in Figure 6. 
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Figure 6: Occurrence of Severe IVH: UMass vs. Von. 
The occurrence of severe IVH in preterm infants at UMass (n=218) was compared to the 
occurrence in preterm infants in the Vermont Oxford Network (n=85175).  The occurrence of IVH 
was extremely statistically significantly lower (***) at UMass than in the Vermont Oxford 
Network with a P value of 0.0004. 
 
 One possible neurodevelopmental complication is cerebral palsy.  To determine if severe 
IVH correlates with cerebral palsy, a Two-tailed Fisher’s Exact Test was performed for ELBW 
infants from the UMMC NICU with and without severe IVH, from 2003 to 2009.  ELBW infants 
with severe IVH were 22% more likely to develop cerebral palsy than ELBW infants without 
IVH.  A Graph of the Occurrence of Cerebral Palsy in Infants with Severe IVH and Infants 
without severe IVH is displayed in Figure 7.   
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Figure 7: Occurrence of Cerebral Palsy: Severe IVH vs. No Severe IVH. 
The occurrence of cerebral palsy in preterm infants with severe IVH (n=17) was s found to be very 
statistically significantly higher (**) in the severe IVH infants than in the no severe IVH infants 
with a P value of 0.0032.  
 
 
 Another possible neurodevelopmental complication is cognitive impairment.  To 
determine if severe IVH correlates with moderate or severe cognitive impairment a Two-tailed 
Fisher’s Exact Test was performed for ELBW infants from the UMMC NICU with and without 
severe IVH, from 2003 to 2009.  ELBW infants with severe IVH were 38% more likely to 
become moderately cognitively impaired than ELBW infants without IVH.  Severe IVH infants 
are no more likely to develop severe cognitive impairment than infants without severe IVH.  A 
Graph of the Occurrence of cognitive impairment in Infants with Severe IVH and Infants without 
severe IVH is displayed in Figure 8.   
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Figure 8:  Cognitive Impairment: Severe IVH vs. No Severe IVH. 
The Cognition of preterm infants with severe IVH (n=17) was compared with the cognition of 
preterm infants without severe IVH (n=158).  All Cognition tests were performed between 14 and 
26 months corrected age.  There was no statistical significant difference in the occurrence of 
severe cognitive impairment in either the severe IVH group or the no severe IVH group with a P 
value of 1.  The infants with severe IVH had a very statistically significantly (**) higher 
occurrence of moderate cognitive impairment than infant without IVH with a P value of 0.0036. 
 
 To determine if there is a correlation between sensory impairment, particularly sight and 
vision, a Two-tailed Fisher’s Exact Test was run to compare the need for eyeglasses and any 
hearing impairment in ELBW infants with and without severe IVH between 2003 and 2009.  
These sensory impairments were found to correlate with severe IVH.  ELBW infants with severe 
IVH were 30% more likely to need eyeglasses than infants without severe IVH.  ELBW infants 
with severe IVH were also 13% more likely to have a hearing impairment.  A graph of the 
occurrence of sensory impairments in infants with and without severe IVH is displayed in 
Figure-9. 
42% 
58% 
0% 
75% 
20% 
5% 
0%
20%
40%
60%
80%
100%
Normal Cognition Moderate Cognitive
Impairment
Severe Cognitive
Impairment
O
cc
u
re
n
ce
(%
) 
Cognitive Impairment 
Severe IVH vs. No Severe IVH 
(2003-2009) 
Severe IVH
No Severe IVH
** 
35 
 
 
Figure 9: Sensory Impairment: Severe IVH vs. No Severe IVH. 
The occurrence of sensory impairments, the need for eyeglasses and any hearing impairment, in 
premature infants with severe IVH (n=17) was compared to the occurrence in infants without 
severe IVH (n=165).  Premature infants with severe IVH had a very statistically significantly (**) 
higher occurrence of the need for eyeglasses with a P value of 0.0027. Severe IVH Infants also 
had a statistically significantly (*) higher occurrence of hearing impairment than did infants 
without severe IVH.  
 
 The occurrence of rehospitalization of ELBW infants with and without severe IVH, 
between 2003 and 2009, was compared using a Two-tailed Fisher’s Exact Test.  There was no 
significant difference between the rehospitalization of infants with and without severe IVH.  No 
correlation between severe IVH and rehospitalization was found.  A graph of the occurrence of 
rehospitalization is displayed as Figure 10. 
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Figure 10: Occurrence of Rehospitalization: No Severe IVH vs. Severe IVH. 
The occurrence of rehospitalization after discharge from the NICU of preterm infants with severe 
IVH (n=17) was compared to its occurrence for preterm infants without IVH (n=162).  The 
Occurrence of rehospitalization was found not to be statistically different in the severe IVH infants 
than in the no severe IVH infants with a P value of 0.1213. 
 
 To determine whether mode of delivery, either vaginal delivery or cesarian section, 
correlates with the grade of severe IVH, a Two-tailed Fisher’s Exact Test was performed.  There 
was no significant difference between the grade of IVH with vaginal delivery or cesarian section.  
Thus, no correlation was found between mode of delivery and severity of IVH.  A graph of this 
comparison can be found in Figure 11. 
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Figure 11: Severity of IVH Compared to Mode of Delivery. 
The severity of IVH, grade 3 (n=8) or grade 4 (n=9), was compared to the mode of delivery, 
vaginal or cesarian section.  No statistically significant difference in grade of severe IVH was 
found based on the mode of delivery, with a P value of 0.6199.   
 
 The severity of IVH was compared to the administration of antenatal steroids with a 
Two-tailed Fisher’s Exact Test.  No significant difference in severity of IVH was found with or 
without the use of antenatal steroids. These results can be seen in Figure 12. 
 
Figure 12: Severity of IVH Compared to Use of Antenatal Steroids. 
The severity of IVH, grade 3 (n=8) or grade 4 (n=9), was compared to the use of antenatal 
steroids.  No statistically significant difference in grade of severe IVH was found based on the use 
of antenatal steroids, with a P value of 0.6199.   
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 Severe IVH was found to have correlations with cerebral palsy, moderate cognitive 
impairments, as well as impairments but not with rehospitalization or severe cognitive 
impairments at UMMC.  No correlation was found between the severity of IVH and the mode of 
delivery or use of antenatal steroids at UMMC.  This information can be used to inform parents 
and aid in the difficult decision of resuscitation and continuation of medical care for their ELBW 
infant. 
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DISCUSSION 
 
 
 
To compare different variables recorded in this severe IVH study, two statistical analytic 
tests were performed, including two-tailed Fisher’s exact test and Chi Squared analysis with 
Yates correction. A Chi Squared analysis with Yates correction shows that there are significantly 
fewer cases of severe IVH at UMass Memorial Medical Center (UMMC) compared with the 
VON Network as a whole. This data suggests that the NICU at UMMC is doing a better job 
stabilizing babies born <1000g than the average VON Network center. The chi squared analysis 
with Yates correction was performed for this comparison because the Fisher’s exact analysis 
could not be performed because of the large population size. Fisher’s exact tests were used for all 
other statistical analyses. Statistical analysis shows a very strong correlation between babies with 
severe IVH and the development of moderate cognitive impairment later in life. However, no 
correlation was found with severe cognitive impairment. At UMMC, there is a very strong 
correlation between babies who had severe IVH and the development of cerebral palsy as an 
infant. In addition, a very strong correlation was found between babies who had severe IVH 
needing eyeglasses later in life due to visual impairments. A strong correlation was found 
between babies, at UMMC, who had severe IVH and the occurrence of hearing impairment. 
These correlations indicate that severe IVH increases the risk of poor neurodevelopmental, motor 
and sensory outcomes.  
According to the Fischer’s exact test there is no statistical significance between the 
incidence of CP at UMMC compared to the VON network, which acts as a positive control, 
showing that UMass Memorial Medical Center is comparable to the VON Network. There was 
also no significant difference in rehospitalization in children who had severe IVH compared to 
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those who did not have severe IVH at UMMC. This indicates that infants at UMMC with severe 
IVH are not at an increase risk of rehospitalization compared to those who did not have severe 
IVH. Other analyses showing no statistical significance were the administration of antenatal 
steroids compared to the grade of severe IVH (grade 3 vs. grade 4), the mode of delivery 
compared to the grade of severe IVH, and the occurrence of cerebral palsy compared to the grade 
of severe IVH. These comparisons likely did not show statistical significance due to small 
sample sizes (Grade 3 IVH, n=8; Grade 4 IVH, n=9). If the populations were larger, likely there 
would be a greater chance of these differences being significant. 
Had the sample sizes been larger for the comparisons of the grade of severe IVH and 
mode of delivery or antenatal steroid use a correlation would likely have been found since these 
correlations have been found with larger populations. The lack of a correlation between severe 
IVH and increased incidence of rehospitalization is also interesting because the expectation 
would be that a correlation would exist between the two, based on previous research. This begs 
the question of whether trends found from analyzing single hospitals with a small population size 
of interest are reliable. If data is pooled over 30 years in order to get a large enough populations, 
size the results of analysis will likely be unreliable due to advances in patient care during those 
30 years. It would be most beneficial to pool data from multiple hospitals for analyzing trends in 
order to have a large enough sample size to obtain reliable correlations over a shorter time 
period.  
The forms created for UMass will allow physicians in the NICU to find these types of 
correlations for babies with various NICU complications born at UMMC. This would allow 
physicians in the NICU to give parents more accurate information regarding the possible 
sensory, motor, neurodevelopmental or other outcomes their child faces in order to make a better 
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educated decision about whether to continue to provide life-sustaining care to their infants who 
may be neurologically devastated.  
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           Appendix 2: Comprehensive List of Variables 
 
Independent Variables 
Gestational age (GA) (criteria: days from LMP (last menstrual period) documented by OB, or 
ultrasound dating 
 
Birth weight 
 
Weight for gestational age  
1. Small for gestational age (SGA) 
2. Average for gestational age (AGA) 
3. Large for gestational age (LGA) 
 
Apgar, 5 minute 
1. Not applicable (N/A) 
2. Score 
AP5 
1-10 
9.  Unknown
Mode of delivery  
1. C-section (CS) 
2. Vaginal 
VAGDEL 
0.  No (C-section)  
1.  Yes 
9.  Unknown 
 
Chronic Lung Disease 
1.  Yes 
0.  No 
7.  Not applicable 
9.  Unknown 
Ox36 
0.  No 
1.  Yes 
7.  Not applicable 
9.  Unknown 
 
Intraventricular Hemorrhage (IVH)  
(highest grade, unilateral or bilateral) 
1. Grade 3 
2.  Grade 4 
Periventricular Leukomalacia  
1. None 
2. Cystic 
3. Diffuse 
UGRADE 
0-4 
7.  Not applicable 
9. Unknown 
 
PVL 
0. No 
1. Yes (Cystic) 
7.  Not applicable 
9.  Unknown
 
 
 
 
 
 
 
 
 
 
 
 
Retinopathy of prematurity (ROP) 
1. None 
2. < Grade 2+ 
3.  Grade 2+ (plus disease) 
4. Grade 3 
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5.  Grade 4 ISTAGE 
0-4 
7.  Not applicable 
9.  Unknown
Retinopathy of prematurity (ROP) laser 
treatment 
1. Not applicable (N/A) 
2. Yes  
3. No  
ROPSURG 
0.  No 
1.  Yes 
7.  Not applicable 
9.  Unknow
Hearing (BAER) 
1. Pass bilaterally 
2. Referred one ear 
3. Referred both ears 
4. Not recorded 
 
Sepsis 
1. None 
2. Symptoms & blood culture (cx) positive 
3. Symptoms and urine culture (cx) 
positive 
4. Symptoms and cerebral spinal fluid (csf) 
culture (cx) positive 
 
SEPSIS 
0.  No 
1.  Yes 
9.  Unknown
Antenatal steroids  
1. None 
2. Betamethasone (BMZ) or Celestone 
3. Other (please note) 
ASTER 
0.  No 
1.  Yes 
9.  Unknown
Antenatal Steroid Doses 
1. Not eligible (criteria: 23-5/7 to 34-0/7 wks gest) 
2. None 
3. 1 dose 
4. 2 doses 
5. Not known 
Chorioamnionitis evidence (maternal 
fever, other mention) 
1. Yes 
2. No 
CHORIO 
0.  No 
1.  Yes 
9.  Unknown
Dependent Variables 
Cerebral palsy (CP) 
1. Yes 
2. No 
 
Cpalsy 
1.  Yes 
0.  No 
CPImp 
1.  Diplegia 
2.  Hemiplegia 
3.   Paraplegia
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Seizures/Epilepsy 
1. Yes 
2. No 
SEIZURE 
0.  No 
1.  Yes 
7.  Not applicable 
9.  Unknown 
 
SeizAdm 
      1. Yes 
      0. No 
Hearing impaired 
1. Yes 
2. No 
 
 
HearImp 
0.  Not impaired 
1.  One ear 
2.  Both ears 
9.  Unsure  
HearingTest 
0.  No 
1.  Yes
Vision impaired 
1. Yes 
2. No 
 
Blindness 
0.  Not blind 
1.  One eye 
2.  Both eyes 
9.  Unsure 
Hospitalizations since NICU discharge 
1. 0 
2. 1 
3. 2 
4. 3 
5. 4+ 
Surgery since NICU discharge 
1. 0 
2. 1 
3. 2 
4. 3 
5. 4+ 
 
Surgery 
0.  No 
1.  Yes 
9.  Unknown
 
 
 
 
 
 
 
 
 
 
 
Bayley Scales of 
Infant 
Development II: 
MDI 
1. Not 
applicable 
(N/A) 
2. MDI score 
 
MDI 
0.  No 
1.  Yes 
 
MDIIndex 
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MDIRaw
Bayley Scales of 
Infant 
Development II: 
PDI 
1. Not 
applicable 
(N/A) 
2. PDI score 
 
PDI 
0.  No 
1.  Yes 
PDIIndex PDIRaw
Bayley Scales of 
Infant and 
Toddler 
Development III: 
Cognitive 
1. Not 
applicable 
(N/A) 
2. Composite 
score 
 
CogComp 
0.  No 
1.  Yes 
CogCompIndex CogCompRaw
Bayley Scales of 
Infant and 
Toddler 
Development III: 
Language 
1. Not 
applicable 
(N/A) 
2. Composite 
score 
 
LangComp 
0.  No 
1.  Yes 
LangCompIndex LangCompRaw
Bayley Scales of 
Infant and 
Toddler 
Development III: 
Motor 
1. Not 
applicable 
(N/A) 
2. Composite 
score 
MotorComp 
0.  No 
1.  Yes 
MotorCompIndex 
 
MotorCompRaw 
 
Appendix 3a: UMass Memorial Medical Center Developmental Status Report (0 to 15-29/30 
months) 
 
Date Last Seen  
(MM/DD/YYYY) 
___/___/_____ 
 
 
SECTION A: GROWTH PARAMETERS 
 
Corrected Age Growth Parameters Were Obtained 
(months/days): __ __ months __ __ days 
 Weight: __  __ . __ __ kg      
 
Head 
Circumference: 
__ __ . __ __ cm      
 Length: __ __ . __ __ cm or __ __ . __ __ in 
 Early Intervention Received: □ Yes   □ No   
 
SECTION B: VISION AND HEARING 
 Formal Ophthalmologic Exam: □ Yes   □ No   
 Blindness: □ One eye   □ Both eyes   □ Not blind  □ Unsure   
 Prescription Glasses: □ Yes    □ No    
 Formal Hearing Test: □ Yes            □ No    
 Hearing Impairment: □ One ear   □ Both ears  □ Not deaf  □ Unsure   
 Amplification: □ Yes   □ No    
 
SECTION C: CEREBRAL PALSY 
 Cerebral Palsy: □ Yes   □ No   
If Yes, a. Impairment: □ Diplegia   □ Hemiplegia  □ Quadriplegia  
If No, b. Muscle tone: □ Hypotonia   □ Hypertonia  □ Both (hypo- & hypertonia)  □ Normal   
 
SECTION D: GROSS MOTOR MILESTONES 
 Sits Independently: □ Yes   □ No   
If No, a. Sits with support: □ Yes   □ No   
 Walks ten (10) steps independently: □ Yes   □ No   
If No, a. Walks ten (10) steps with support: □ Yes   □ No   
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SECTION E: DEVELOPMENTAL TESTING 
Bayley Scales of Infant Development: □ Completed   □ Partly Completed   □ Not Performed   
If completed or partially completed, 
a. Corrected age used in scoring: __ __ months __  __ days 
b. Results:  Check all sections that apply. 
□ 
BSID-II    
MDI: Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-II    
PDI:  Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-III    
Cognitive:  Scaled Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Language:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Motor:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
 
BINS: □ L     
 □ M   
 □ H    
   
 
IF partly completed or not performed, 
Check why: □ Neurosensory impairment (blind or deaf)   □ Too severely delayed   
 □ Uncooperative   □ Other reason: ____________________________  
Other Developmental Test Performed: □ Yes   □ No   
If Yes, Abnormal results: □ Yes   □ No   
 
 
SECTION F: OVERALL CLINICAL APPRAISAL 
Clinical Appraisal: Cognitive Function: □ Normal   □ Suspect   □ Impaired   
  Language: □ Normal   □ Suspect   □ Impaired   
  Motor Function: □ Normal   □ Suspect   □ Impaired   
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Appendix 3b: UMass Memorial Medical Center Health Status Report (0 to 15-29/30 
months) 
 
Date Last Seen 
(MM/DD/YYYY) 
___/___/_____ 
 
 
Birth Weight (g): □ <1000   □ 1000-1250   □ 1251-2000   □ 2001-2500   □ >2500   
Gestational Age (weeks): □ <28   □ 28 – 38   □ 30 1/7-34   
 □ 34 1/7 -36 6/7   □ 37 – 42   □ >42   
 
 
SECTION A: HEALTH STATUS 
Corrected Age at the Follow-Up Visit: 
(months/days) 
__ __ months __ __ days 
 
 
SECTION B: LIVING SITUATION 
Maternal Age at Infant Birth: __ __ Years □ Unknown   
Home Child Resides: □ Parent/Family Member   □ Foster Care   □ Chronic care facility   
Caregiver(s):    
(Check only one) 
□ Single Parent   □ 
Single parent 
extended Family   
□ Institutional   
 □ Two Parents   □ Two parent extended family   
Primary Caregiver 
Education: 
□ 
Some high school  
or less  
□ Some college/university   
(Check only one) 
□ 
High school 
degree/GED   
□ College /university degree   
 □ Not applicable  □ Unknown  
Caregiver(s) Primary Language: □ English   □ Spanish   □ Other:   __________ 
 
 
SECTION C: SUPPORT AFTER DISCHARGE        
                    
Support After NICU Discharge: □ Yes   □ No   □ Unsure    
If Yes,  Check all that apply 
□ 1. Tracheostomy   □ 4.  Gastrostomy   
□ 2.  Ventilator   □ 5.  Nasogastric Feeds   
□ 3.  Oxygen   □ 6.  Apnea or Cardio Respiratory Monitor   
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SECTION D: MEDICAL HOSPITALIZATION & SURGERIES 
Medical Hospitalization After NICU Discharge: □ Yes   □ No   □ Unsure   
If Yes, Category:   
Check all that apply 
Number of 
Admissions 
  Number of 
Admissions 
□ 1. Respiratory Illness   __ __ □ 5. Infections (not respiratory 
of shunt infections):   
__ __ 
□ 2. Nutrition/Failure to Thrive   __ __ □ a. Meningitis   __ __ 
□ 3. Seizure Complications   __ __ □ b. Urinary Tract Infection   __ __ 
□ 4. Shunt Complication   __ __ □ c. Gastrointestinal Infection   __ __ 
   □ d. Other Infection   __ __ 
     (Specify)_______________________ 
□ 6. Other Medical Hospitalizations:   (Specify)______________________________________ 
 
 
SURGICAL PROCEDURE CODES (P-CODES) 
CODE PROCEDURE  
 Central Nervous System  
P-101 Shunt or shunt revision for hydrocephalus  
P-102 Other neurosurgical procedure  
 Congenital Heart Defect Surgery  
P-201 Cardiac surgery  
 Gastrointestinal Surgery  
P-301 Gastrostomy tube  
P-302 Inguinal hernia repair  
P-303 Other gastrointestinal surgical procedure  
 Genitourinary Surgery  
P-401 Circumcision  
P-402 Other genitourinary surgical procedure  
 Otolaryngology  
P-501 Tracheostomy   
P-502 Tympanostomy tubes  
P-503 Other ENT surgical procedures  
 Ophthalmologic Surgery  
P-601 Retinal cryosurgery or laser surgery: single eye  
P-602 Retinal cryosurgery or laser surgery: both eye  
P-603 Strabismus surgery  
P-604 Other ophthalmological surgical procedure  
P-900 Other Surgical Procedures  
 
Surgical Procedures After NICU Discharge: □ Yes   □ No   □ Unsure   
  Number of Procedures 
(P-Codes) _________________________ __ __  
 _________________________ __ __  
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Appendix 3c: UMass Memorial Medical Center Developmental Status Report (VON: 16 to 
26 months) 
 
Center Number: ____________ Center Name: ___________________________________________ 
Network ID 
Number: 
______________ 
Year of Birth: 
(YYYY) 
__________ 
Date Last Seen: 
(MM/DD/YYYY) 
___/___/_____ 
 
 
SECTION A: GROWTH PARAMETERS 
 
Corrected Age Growth Parameters Were Obtained 
(months/days): __ __ months  __ __ days 
 Weight: __ __ . __ __ kg 
 
Head 
Circumference: 
__ __ . __ __ cm 
 Height: __ __ . __ __ cm or __ __ . __ __ in 
 Early Intervention Received: □ Yes   □ No   
 
SECTION B: VISION AND HEARING 
 Formal Ophthalmologic Exam: □ Yes   □ No   
 Blindness: □ One eye   □ Both eyes   □ Not blind   □ Unsure   
 Prescription Glasses: □ Yes   □ No   
 Formal Hearing Test: □ Yes   □ No   
 Hearing Impairment: □ One ear   □ Both ears   □ Not deaf   □ Unsure   
 Amplification: □ Yes   □ No   
 
SECTION C: CEREBRAL PALSY 
 Cerebral Palsy: □ Yes   □ No   
If Yes, a. Impairment: □ Diplegia   □ Hemiplegia   □ Quadriplegia   
If No, b. Muscle tone: □ Hypotonia   □ Hypertonia   □ Both (hypo- & hypertonia)  □ Normal   
 
SECTION D: GROSS MOTOR MILESTONES 
 Sits Independently: □ Yes   □ No   
If No, a. Sits with support: □ Yes   □ No   
 Walks ten (10) steps independently: □ Yes   □ No   
If No, a. Walks ten (10) steps with support: □ Yes   □ No   
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SECTION E: DEVELOPMENTAL TESTING 
Bayley Scales of Infant Development: □ Completed   □ Partly Completed   □ Not Performed   
If completed or partially completed, 
a. Corrected age used in scoring: __ __ months __  __ days 
b. Results:  Check all sections that apply. 
□ 
BSID-II    
MDI: Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-II    
PDI: Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-III    
Cognitive:  
Scaled 
Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Language:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Motor:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
 
Mullen: 
 
Domain 
Age 
Equivalent Descriptive Category 
Gains from 
last visit 
(months) (months) 
GM __ __ □ 
very 
 low  
□ 
below 
average  
□ average   □ 
above 
average  
□ 
very 
high  
__ __ 
VR __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average  
□ 
very 
high  
__ __ 
FM __ __ □ 
very 
low   
□ 
below 
average  
□ average    
□ above 
average   
□ 
very 
high  
__ __ 
RL __ __ □ 
very 
low   
□ 
below 
  average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
EL __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
 
ADOS: □ No     BINS: □ L      
 □ ASC    □ M   
 □ AC      □ H     
IF partly completed or not performed, 
 Check why: □ Neurosensory impairment (blind or deaf)   □ Too severely delayed   
 □ Uncooperative   □ Other reason:   ___________________________ 
Other Developmental Test Performed: □ Yes   □ No   
If Yes, Abnormal results: □ Yes   □ No   
 
 
SECTION F: OVERALL CLINICAL APPRAISAL 
 
Clinical 
Appraisal: 
Cognitive 
Function: □ 
Normal   
□ 
Suspect   
□ 
Impaired   
  Language: □ Normal  □ Suspect   □ Impaired   
  Motor Function: □ Normal   □ Suspect   □ Impaired   
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Appendix 3d: UMass Memorial Medical Center Health Status Report (VON: 16 to 26 
months) 
 
Center Number: __________ Center Name: ________________________________________ 
Network ID Number: __________ 
Year of Birth 
(YYYY): 
______ 
Date Last Seen 
(MM/DD/YYYY) 
___/___/_____ 
 
 
Birth Weight (g): □ <1000   □ 1000-1250   □ 1251-2000   □ 2001-2500   □ >2500   
Gestational Age (weeks): □ <28   □ 28 – 38   □ 30 1/7-34   
 □ 34 1/7 -36 6/7   □ 37 – 42   □ >42   
 
 
SECTION A: HEALTH STATUS 
Status at 18-24 Months Corrected Age: □ Alive   □ Expired   □ Unknown   
Consent Obtained at the Follow-Up-Visit: □ Yes   □ No   
Corrected Age at the Follow-Up Visit: 
(months/days) 
__ __ months __ __ days 
 
 
SECTION B: LIVING SITUATION 
Maternal Age at Infant Birth: __ __ Years □ Unknown   
Home Child Resides: □ Parent/Family Member   □ Foster Care   □ Chronic care facility   
Caregiver(s):     
(Check only one) 
□ Single Parent   □ 
Single parent 
extended Family   
□ Institutional   
 □ Two Parents   □ Two parent extended family   
Primary Caregiver 
Education: 
□ Some high school or less  □ Some college/university   
(Check only one) □ High school degree/GED   □ College /university degree   
 □ Not applicable  □ Unknown  
Caregiver(s) Primary Language: □ English   □ Spanish   □ Other:   __________ 
 
 
SECTION C: SUPPORT AFTER DISCHARGE 
 
Support After NICU Discharge: □ Yes   □ No   □ Unsure     
If Yes,  Check all that apply 
□ 1. Tracheostomy  □ 4.  Gastrostomy   
□ 2.  Ventilator   □ 5.  Nasogastric Feeds   
□ 3.  Oxygen   □ 6.  Apnea or Cardio Respiratory Monitor   
 
 
 
SECTION D: MEDICAL HOSPITALIZATION & SURGERIES 
 67 
Medical re-hospitalization after ultimate discharge: □ Yes   □ No   □ Unsure   
If Yes, Category:   
Check all that apply 
Number of 
Admissions 
  Number of 
Admissions 
□ 1. Respiratory Illness   __ __ □ 5. Infections (not respiratory 
of shunt infections):   
__ __ 
□ 2. Nutrition/Failure to Thrive   __ __ □ a. Meningitis   __ __ 
□ 3. Seizure Complications   __ __ □ b. Urinary Tract Infection   __ __ 
□ 4. Shunt Complication   __ __ □ c. Gastrointestinal Infection   __ __ 
   □ d. Other Infection   __ __ 
     (Specify)_______________________ 
□ 6. Other Medical Hospitalizations:   (Specify)______________________________________ 
  
Surgical procedures after discharge: □ Yes   □ No   □ Unsure   
   Number of Procedures 
(P-Codes) _________________________ __ __  
  _________________________ __ __  
SURGICAL PROCEDURE CODES (P-CODES) 
 
CODE PROCEDURE  
 Central Nervous System  
P-101 Shunt or shunt revision for hydrocephalus  
P-102 Other neurosurgical procedure  
 Congenital Heart Defect Surgery  
P-201 Cardiac surgery  
 Gastrointestinal Surgery  
P-301 Gastrostomy tube  
P-302 Inguinal hernia repair  
P-303 Other gastrointestinal surgical procedure  
 Genitourinary Surgery  
P-401 Circumcision  
P-402 Other genitourinary surgical procedure  
 Otolaryngology  
P-501 Tracheostomy   
P-502 Tympanostomy tubes  
P-503 Other ENT surgical procedures  
 Ophthamologic Surgery  
P-601 Retinal cryosurgery or laser surgery: single eye  
P-602 Retinal cryosurgery or laser surgery: both eye  
P-603 Strabismus surgery  
P-604 Other ophthamological surgical procedure  
P-900 Other Surgical Procedures  
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Appendix 3e: UMass Memorial Medical Center Developmental Status Report (26-1/30 to 
42 months) 
 
Date Last Seen  
(MM/DD/YYYY) 
___/___/_____ 
 
 
 
SECTION A: GROWTH PARAMETERS 
 
Corrected Age Growth Parameters Were Obtained 
(months/days): __ __ months  __ __ days 
 Weight: __ __ . __ __ kg 
 
Head 
Circumference: 
__ __ . __ __ cm 
 Height: __ __ . __ __ cm or __ __ . __ __ in 
 Early Intervention Received: □ Yes   □ No   
 
SECTION B: VISION AND HEARING 
 Formal Ophthalmologic Exam: □ Yes   □ No   
 Blindness: □ One eye   □ Both eyes   □ Not blind   □ Unsure   
 Prescription Glasses: □ Yes   □ No   
 Formal Hearing Test: □ Yes   □ No   
 Hearing Impairment: □ One ear   □ Both ears   □ Not deaf   □ Unsure   
 Amplification: □ Yes   □ No   
 
SECTION C: CEREBRAL PALSY 
 Cerebral Palsy: □ Yes   □ No   
If Yes, a. Impairment: □ Diplegia   □ Hemiplegia   □ Quadriplegia   
If No, b. Muscle tone: □ Hypotonia   □ Hypertonia   □ Both (hypo- & hypertonia)  □ Normal   
 
SECTION D: GROSS MOTOR MILESTONES 
 Sits Independently: □ Yes   □ No   
If No, a. Sits with support: □ Yes   □ No   
 Walks ten (10) steps independently: □ Yes   □ No   
If No, a. Walks ten (10) steps with support: □ Yes   □ No   
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SECTION E: DEVELOPMENTAL TESTING 
Bayley Scales of Infant Development: □ Completed   □ Partly Completed   □ Not Performed   
If completed or partially completed: 
a. Corrected age used in scoring: __ __ months __  __ days 
b. Results:  Check and complete all sections that apply: 
□ 
BSID-II    
MDI: Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-II    
PDI:  Raw Score: __  __  __ Index Score for Corrected Age: __  __  __ 
□ 
BSID-III    
Cognitive:  
Scaled 
Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Language:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
□ 
BSID-III    
Motor:  
Sum Scaled 
Score: __  __  __ Composite Score: __  __  __ 
 
Mullen: 
 
Domain 
Age 
Equivalent Descriptive Category 
Gains from 
last visit 
(months) (months) 
GM __ __ □ 
very 
 low  
□ 
below 
average  
□ average   □ 
above 
average  
□ 
very 
high  
__ __ 
VR __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
FM __ __ □ 
very 
low   
□ 
below 
average  
□ average    
□ above 
average   
□ 
very 
high  
__ __ 
RL __ __ □ 
very 
low   
□ 
below 
  average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
EL __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
 
 
 
 
IF partly completed or not performed check why: 
 Check why: □ Neurosensory impairment (blind or deaf)   □ Too severely delayed   
 □ Uncooperative   □ Other reason:   ___________________________ 
Other Developmental Test Performed: □ Yes   □ No   
If Yes, Abnormal results: □ Yes   □ No   
 
SECTION F: OVERALL CLINICAL APPRAISAL 
Clinical Appraisal: Cognitive Function: □ Normal □ Suspect □ Impaired 
  Language: □ Normal   □ Suspect   □ Impaired   
  Motor Function: □ Normal   □ Suspect   □ Impaired   
 
 
 
ADOS: □ No     module □ 1   □ 3    
 □ ASC    □ 2   □ 4    
 □ AC          
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Appendix 3f: UMass Memorial Medical Center Health Status Report (26-1/30 months and 
older) 
 
Date Last Seen 
(MM/DD/YYYY) 
___/___/_____ 
 
 
Birth Weight (g): □ <1000   □ 1000-1250   □ 1251-2000   □ 2001-2500   □ >2500   
Gestational Age (weeks): □ <28   □ 28 – 38   □ 30 1/7-34   
 □ 34 1/7 -36 6/7   □ 37 – 42   □ >42   
 
 
SECTION A: HEALTH STATUS 
Corrected Age at the Follow-Up Visit: 
(months/days) 
__ __ months __ __ days 
 
 
SECTION B: LIVING SITUATION 
Maternal Age at Infant Birth: __ __ Years □ Unknown   
Home Child Resides: □ Parent/Family Member   □ Foster Care   □ 
Chronic care 
facility   
Caregiver(s):     
(Check only one) 
□ Single Parent   □ 
Single parent 
extended Family   
□ Institutional   
 □ Two Parents   □ Tw0 parent extended family   
Primary Caregiver 
Education: 
□ Some high school or less  □ Some college/university   
(Check only one) □ High school degree/GED   □ College /university degree   
 □ Not applicable  □ Unknown  
Caregiver(s) Primary Language: □ English   □ Spanish   □ Other:   __________ 
 
 
SECTION C: SUPPORT AFTER DISCHARGE        
                    
Support After NICU Discharge: □ Yes   □ No   □ Unsure    
If Yes,  Check all that apply 
□ 1. Tracheostomy   □ 4.  Gastrostomy   
□ 2.  Ventilator   □ 5.  Nasogastric Feeds   
□ 3.  Oxygen   □ 6.  Apnea or Cardio Respiratory Monitor   
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SECTION D: MEDICAL HOSPITALIZATION & SURGERIES 
Medical re-hospitalization since last seen: □ Yes   □ No   □ Unsure   
If Yes, Category:  Check all that 
apply 
Number of 
Admissions 
  Number of 
Admissions 
□ 1. Respiratory Illness   __ __ □ 5. Infections (not respiratory 
of shunt infections):   
__ __ 
□ 2. Nutrition/Failure to Thrive   __ __ □ a. Meningitis   __ __ 
□ 3. Seizure Complications   __ __ □ b. Urinary Tract Infection   __ __ 
□ 4. Shunt Complication   __ __ □ c. Gastrointestinal Infection   __ __ 
   □ d. Other Infection   __ __ 
     (Specify)_______________________ 
□ 6. Other Medical Hospitalizations:   (Specify)______________________________________ 
  
Surgical procedures since last seen: □ Yes   □ No   □ Unsure   
   Number of Procedures 
 (P-Codes) _________________________ __ __  
  _________________________ __ __  
 
SURGICAL PROCEDURE CODES (P-CODES) 
CODE PROCEDURE  
 Central Nervous System  
P-101 Shunt or shunt revision for hydrocephalus  
P-102 Other neurosurgical procedure  
 Congenital Heart Defect Surgery  
P-201 Cardiac surgery  
 Gastrointestinal Surgery  
P-301 Gastrostomy tube  
P-302 Inguinal hernia repair  
P-303 Other gastrointestinal surgical procedure  
 Genitourinary Surgery  
P-401 Circumcision  
P-402 Other genitourinary surgical procedure  
 Otolaryngology  
P-501 Tracheostomy   
P-502 Tympanostomy tubes  
P-503 Other ENT surgical procedures  
 Ophthalmologic Surgery  
P-601 Retinal cryosurgery or laser surgery: single eye  
P-602 Retinal cryosurgery or laser surgery: both eye  
P-603 Strabismus surgery  
P-604 Other ophthalmological surgical procedure  
P-900 Other Surgical Procedures  
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Appendix 3g: UMass Memorial Medical Center Developmental Status Report (42.1 months 
and older) 
 
Date Last Seen  
(MM/DD/YYYY) 
___/___/_____ 
 
 
SECTION A: GROWTH PARAMETERS 
 
Corrected Age Growth Parameters Were Obtained 
(months/days): __ __ months  __ __ days 
 Weight: __ __ . __ __ kg 
 
Head 
Circumference: 
__ __ . __ __ cm 
 Height: __ __ . __ __ cm or __ __ . ____ in 
 Early Intervention Received: □ Yes   □ No   
 
SECTION B: VISION AND HEARING 
 Formal Ophthalmologic Exam: □ Yes   □ No   
 Blindness: □ One eye   □ Both eyes   □ Not blind   □ Unsure   
 Prescription Glasses: □ Yes   □ No   
 Formal Hearing Test: □ Yes   □ No   
 Hearing Impairment: □ One ear   □ Both ears   □ Not deaf   □ Unsure   
 Amplification: □ Yes   □ No   
 
SECTION C: CEREBRAL PALSY 
 Cerebral Palsy: □ Yes   □ No   
If Yes, a. Impairment: □ Diplegia   □ Hemiplegia   □ Quadriplegia   
If No, b. Muscle tone: □ Hypotonia   □ Hypertonia   □ Both (hypo- & hypertonia)  □ Normal   
 
SECTION D: GROSS MOTOR MILESTONES 
 Sits Independently: □ Yes   □ No   
If No, a. Sits with support: □ Yes   □ No   
 Walks ten (10) steps independently: □ Yes   □ No   
If No, a. Walks ten (10) steps with support: □ Yes   □ No   
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SECTION E: DEVELOPMENTAL TESTING 
 
Mullen: 
 
Domain 
Age 
Equivalent Descriptive Category 
Gains from 
last visit 
(months) (months) 
GM __ __ □ 
very 
 low  
□ 
below 
average  
□ average   □ 
above 
average  
□ 
very 
high  
__ __ 
VR __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
FM __ __ □ 
very 
low   
□ 
below 
average  
□ average    
□ above 
average   
□ 
very 
high  
__ __ 
RL __ __ □ 
very 
low   
□ 
below 
  average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
EL __ __ □ 
very 
low   
□ 
below 
average  
□ average   
□ above 
average   
□ 
very 
high  
__ __ 
 
ADOS: □ No   module □ 1   □ 3    
 □ ASC    □ 2   □ 4    
 □ AC        
KBIT-2: __ __ __ V (verbal)   
 __ __ __ N (non-verbal)   
WRAT:  __ __ __ WR (word reading)   
 __ __ __ 
SC (sentence 
comprehension)   
  __ __ __ S (spelling)   
Einstein: □  A (Acceptable)   
 □ U (Unacceptable)   
 
IF partly completed or not performed, check why: 
□ Neurosensory impairment (blind or deaf)   □ Too severely delayed   
□ Uncooperative   □ Other reason:   ___________________________ 
Other Developmental Test Performed: □ Yes   □ No   
If Yes, Abnormal results: □ Yes   □ No   
 
SECTION F: OVERALL CLINICAL APPRAISAL 
Clinical Appraisal: Cognitive Function: □ Normal   □ Suspect   □ Impaired   
  Language: □ Normal   □ Suspect   □ Impaired   
  Motor Function: □ Normal   □ Suspect   □ Impaired   
 
 
 
 
